Filter by patients with: All

What is Abemaciclib?

Category: Prescription Drugs

Most popular types: Verzenio

false

Abemaciclib is a targeted treatment for breast cancer; it is specific to HR+/HER2− (hormone receptor positive/human epidermal growth factor receptor 2 negative) patients with metastasis.

See patients taking Abemaciclib

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Breast cancer 3 1
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 5 patients that have taken Abemaciclib

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 1
Mild 0
None 0

Commonly reported side effects and conditions associated with Abemaciclib

Side effect Patients Percentage
Fatigue 1
Adherence
Adherence Evaluations Percentage
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 0

What people switch to and from

Patients started taking Abemaciclib after stopping:

Treatment Patients Percentage
Gabapentin (Neurontin) 1
Paclitaxel (Taxol) 1
Last updated:
There are no evaluations for Abemaciclib.